Scarica l'app Stockscreener
339.30
0.17%
0.58
Precedente Chiudi:
$338.72
Aprire:
$338.84
Volume 24 ore:
551.72K
Relative Volume:
0.61
Capitalizzazione di mercato:
$13.31B
Reddito:
$1.24B
Utile/perdita netta:
$42.23M
Rapporto P/E:
320.09
EPS:
1.06
Flusso di cassa netto:
$150.33M
1 W Prestazione:
-0.50%
1M Prestazione:
+12.74%
6M Prestazione:
+31.83%
1 anno Prestazione:
+24.34%
Intervallo 1D:
$338.84
$341.66
Intervallo di 1 settimana:
$337.63
$341.66
Portata 52W:
$221.26
$362.41
Penumbra Inc Stock (PEN) Company Profile
Nome
Penumbra Inc
Settore
Industria
Telefono
(510) 995-2486
Indirizzo
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
339.30 | 13.29B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-11-18 | Iniziato | Wells Fargo | Underweight |
| 2025-10-08 | Aggiornamento | Needham | Hold → Buy |
| 2025-09-02 | Iniziato | Evercore ISI | Outperform |
| 2025-03-14 | Iniziato | BofA Securities | Buy |
| 2025-01-21 | Iniziato | UBS | Buy |
| 2024-12-17 | Iniziato | Oppenheimer | Outperform |
| 2024-12-11 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | Iniziato | Stifel | Buy |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-31 | Downgrade | Citigroup | Buy → Neutral |
| 2024-07-31 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-09-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-03-29 | Downgrade | Needham | Buy → Hold |
| 2023-01-30 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-10-05 | Downgrade | Citigroup | Buy → Neutral |
| 2022-09-09 | Aggiornamento | Needham | Hold → Buy |
| 2022-07-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-04-19 | Iniziato | Deutsche Bank | Buy |
| 2022-03-08 | Iniziato | Needham | Hold |
| 2021-09-16 | Iniziato | Truist | Buy |
| 2021-06-04 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-07 | Ripresa | Canaccord Genuity | Buy |
| 2020-09-29 | Iniziato | BTIG Research | Buy |
| 2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-05-30 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-05-21 | Iniziato | William Blair | Outperform |
| 2018-10-29 | Ripresa | BofA/Merrill | Buy |
| 2018-10-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-02-21 | Iniziato | William Blair | Outperform |
| 2018-01-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-13 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Penumbra Inc Borsa (PEN) Ultime notizie
Candriam S.C.A. Trims Stake in Penumbra, Inc. $PEN - MarketBeat
The Truth About Penumbra Inc: Why Wall Street Is Watching While TikTok Sleeps On It - AD HOC NEWS
Wesbanco Bank Inc. Purchases New Position in Penumbra, Inc. $PEN - MarketBeat
Penumbra (PEN) Projected to Post Earnings on Tuesday - MarketBeat
Has Penumbra (PEN) Risen Too Far After Strong One Year Share Price Gain? - Yahoo Finance
Penumbra Sale To Boston Scientific Recasts Growth Story For Investors - Sahm
Penumbra, Inc. $PEN Stock Holdings Lowered by Principal Financial Group Inc. - MarketBeat
Penumbra (PEN) Reported Revenue Growth of 16.9% in Q4 - Insider Monkey
AGF Management Ltd. Makes New $3.14 Million Investment in Penumbra, Inc. $PEN - MarketBeat
Hantz Financial Services Inc. Lowers Position in Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. (PEN): A Bull Case Theory - Finviz
Boston Scientific earnings on deck after Q3 miss, Penumbra deal By Investing.com - Investing.com Canada
AI Stocks: Is Penumbra Inc on track to beat earningsJuly 2025 Momentum & Risk Managed Investment Signals - baoquankhu1.vn
Halper Sadeh LLC Reminds Shareholders of RAPT, PEN, CVGW, FONR of the Firm’s Investigations - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Thrivent Financial for Lutherans Purchases 44,185 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. $PEN Shares Acquired by New York State Common Retirement Fund - MarketBeat
Penumbra Acquisition Finalized in Multi-Billion Dollar Deal with Boston Scientific - AD HOC NEWS
Boston Scientific Reshapes Portfolio With Nalu And Penumbra Neuro Deals - Yahoo Finance
Penumbra, Inc. (NYSE:PEN) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Y Intercept Hong Kong Ltd Cuts Position in Penumbra, Inc. $PEN - MarketBeat
Boston Scientific (BSX) garnering bullish views amid Penumbra acquisition - MSN
Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings - TechStock²
Boston Scientific (BSX) Garnering Bullish Views Amid Penumbra Acquisition - Yahoo Finance
Hussman Strategic Advisors Inc. Makes New Investment in Penumbra, Inc. $PEN - MarketBeat
Boston Scientific to acquire Alameda-based Penumbra for $14.5 billion - MSN
Halper Sadeh LLC Investigates Penumbra and RAPT Transactions - intellectia.ai
The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants - FinancialContent
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA - Sahm
Halper Sadeh Investigates Potential Violations by Penumbra, Amicus, DigitalBridge, and Flushing Financial - intellectia.ai
Strs Ohio Cuts Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
Boston Scientific Buyout Caps Penumbra Upside And Shifts Investor Focus - Sahm
EFG Asset Management North America Corp. Acquires 3,631 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra launches next-gen Lightning Flash 3.0 thrombectomy system - MassDevice
Fed Meeting: Is Penumbra Inc likely to announce a buybackJuly 2025 Rallies & Daily Profit Focused Stock Screening - baoquankhu1.vn
Boston Scientific Penumbra Deal Recasts Growth Prospects In Thrombectomy And Neurovascular - Sahm
Baillie Gifford & Co. Sells 13,581 Shares of Penumbra, Inc. $PEN - MarketBeat
Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. - Barron's
Price Over Earnings Overview: Penumbra - Benzinga
Boston Scientific announces agreement to acquire Penumbra, Inc. - Quantisnow
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—PEN, DBRG, FFIC, and FOLD - GlobeNewswire
Halper Sadeh Investigates Potential Securities Violations by Penumbra, Exact Sciences, DigitalBridge, and Flushing Financial - Intellectia AI
Boston Sci secures CE mark for Embold system - BioWorld MedTech
Penumbra (NYSE:PEN) Sets New 52-Week HighWhat's Next? - MarketBeat
Penumbra Inc stock hits all-time high at 352.3 USD By Investing.com - Investing.com Nigeria
Halper Sadeh Investigates Penumbra and Others for Potential Violations - Intellectia AI
Penumbra (PEN) Sees Downgrade with Revised Price Target from Can - GuruFocus
Risk Report: Is ALTGs ROE strong enoughJuly 2025 Big Picture & Weekly Setup with High ROI Potential - baoquankhu1.vn
Penumbra Inc Azioni (PEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.33%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):